nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia
|
Chen, Gang |
|
2016 |
68 |
4 |
p. 782-786 5 p. |
artikel |
2 |
Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia
|
Chen, Gang |
|
|
68 |
4 |
p. 782-786 |
artikel |
3 |
A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity
|
Ogłodek, Ewa A. |
|
2016 |
68 |
4 |
p. 756-763 8 p. |
artikel |
4 |
A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity
|
Ogłodek, Ewa A. |
|
|
68 |
4 |
p. 756-763 |
artikel |
5 |
Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
|
Bilski, Jan |
|
2016 |
68 |
4 |
p. 827-836 10 p. |
artikel |
6 |
Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
|
Bilski, Jan |
|
|
68 |
4 |
p. 827-836 |
artikel |
7 |
Circadian rhythm abnormalities – Association with the course of inflammatory bowel disease
|
Sobolewska-Włodarczyk, Aleksandra |
|
2016 |
68 |
4 |
p. 847-851 5 p. |
artikel |
8 |
Circadian rhythm abnormalities — Association with the course of inflammatory bowel disease
|
Sobolewska-Włodarczyk, Aleksandra |
|
|
68 |
4 |
p. 847-851 |
artikel |
9 |
Circulatory effect of TCS-80, a new imidazoline compound, in rats
|
Boblewski, Konrad |
|
2016 |
68 |
4 |
p. 715-719 5 p. |
artikel |
10 |
Circulatory effect of TCS-80, a new imidazoline compound, in rats
|
Boblewski, Konrad |
|
|
68 |
4 |
p. 715-719 |
artikel |
11 |
Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
|
Michalak, Arkadiusz |
|
2016 |
68 |
4 |
p. 837-846 10 p. |
artikel |
12 |
Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
|
Michalak, Arkadiusz |
|
|
68 |
4 |
p. 837-846 |
artikel |
13 |
Current and future trends in the lipid lowering therapy
|
Okopień, Bogusław |
|
2016 |
68 |
4 |
p. 737-747 11 p. |
artikel |
14 |
Current and future trends in the lipid lowering therapy
|
Okopień, Bogusław |
|
|
68 |
4 |
p. 737-747 |
artikel |
15 |
Editorial Board
|
|
|
2016 |
68 |
4 |
p. iii- 1 p. |
artikel |
16 |
Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice
|
Karkhaneh, Leyla |
|
2016 |
68 |
4 |
p. 720-727 8 p. |
artikel |
17 |
Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice
|
Karkhaneh, Leyla |
|
|
68 |
4 |
p. 720-727 |
artikel |
18 |
Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease
|
Uranga, José Antonio |
|
2016 |
68 |
4 |
p. 816-826 11 p. |
artikel |
19 |
Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease
|
Uranga, José Antonio |
|
|
68 |
4 |
p. 816-826 |
artikel |
20 |
Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes
|
Potęga, Agnieszka |
|
2016 |
68 |
4 |
p. 663-670 8 p. |
artikel |
21 |
Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes
|
Potęga, Agnieszka |
|
|
68 |
4 |
p. 663-670 |
artikel |
22 |
Inflammatory bowel diseases and reproductive health
|
Kokoszko-Bilska, Agnieszka |
|
2016 |
68 |
4 |
p. 859-864 6 p. |
artikel |
23 |
Inflammatory bowel diseases and reproductive health
|
Kokoszko-Bilska, Agnieszka |
|
|
68 |
4 |
p. 859-864 |
artikel |
24 |
Inflammatory bowel disease treatment
|
Fichna, Jakub |
|
2016 |
68 |
4 |
p. 787-788 2 p. |
artikel |
25 |
Inflammatory bowel disease treatment
|
Fichna, Jakub |
|
|
68 |
4 |
p. 787-788 |
artikel |
26 |
Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures
|
Chrościńska-Krawczyk, Magdalena |
|
2016 |
68 |
4 |
p. 680-685 6 p. |
artikel |
27 |
Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures
|
Chrościńska-Krawczyk, Magdalena |
|
|
68 |
4 |
p. 680-685 |
artikel |
28 |
Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy
|
Zatorski, Hubert |
|
2016 |
68 |
4 |
p. 809-815 7 p. |
artikel |
29 |
Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy
|
Zatorski, Hubert |
|
|
68 |
4 |
p. 809-815 |
artikel |
30 |
Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes
|
Galien, René |
|
2016 |
68 |
4 |
p. 789-796 8 p. |
artikel |
31 |
Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes
|
Galien, René |
|
|
68 |
4 |
p. 789-796 |
artikel |
32 |
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
|
Fabisiak, Adam |
|
2016 |
68 |
4 |
p. 802-808 7 p. |
artikel |
33 |
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
|
Fabisiak, Adam |
|
|
68 |
4 |
p. 802-808 |
artikel |
34 |
l-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test
|
Orzelska-Gorka, Jolanta |
|
2016 |
68 |
4 |
p. 728-732 5 p. |
artikel |
35 |
l-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test
|
Orzelska-Gorka, Jolanta |
|
|
68 |
4 |
p. 728-732 |
artikel |
36 |
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile
|
Jaeschke, Rafał R. |
|
2016 |
68 |
4 |
p. 748-755 8 p. |
artikel |
37 |
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile
|
Jaeschke, Rafał R. |
|
|
68 |
4 |
p. 748-755 |
artikel |
38 |
Narrow time window of metabolic changes associated with transition to overt heart failure in Tgaq*44 mice
|
Czarnowska, Elżbieta |
|
2016 |
68 |
4 |
p. 707-714 8 p. |
artikel |
39 |
Narrow time window of metabolic changes associated with transition to overt heart failure in Tgaq*44 mice
|
Czarnowska, Elżbieta |
|
|
68 |
4 |
p. 707-714 |
artikel |
40 |
Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases
|
Manayi, Azadeh |
|
2016 |
68 |
4 |
p. 671-679 9 p. |
artikel |
41 |
Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases
|
Manayi, Azadeh |
|
|
68 |
4 |
p. 671-679 |
artikel |
42 |
Opioid-induced redistribution of 6TM and 7TM μ opioid receptors: A hypothesized mechanistic facilitator model of opioid-induced hyperalgesia
|
Wang, Wei |
|
2016 |
68 |
4 |
p. 686-691 6 p. |
artikel |
43 |
Opioid-induced redistribution of 6TM and 7TM μ opioid receptors: A hypothesized mechanistic facilitator model of opioid-induced hyperalgesia
|
Wang, Wei |
|
|
68 |
4 |
p. 686-691 |
artikel |
44 |
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle
|
Ibarra-Lara, Luz |
|
2016 |
68 |
4 |
p. 692-702 11 p. |
artikel |
45 |
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle
|
Ibarra-Lara, Luz |
|
|
68 |
4 |
p. 692-702 |
artikel |
46 |
Pharmacokinetics of paracetamol in patients with chronic pancreatitis
|
Siepsiak, Magdalena |
|
2016 |
68 |
4 |
p. 733-736 4 p. |
artikel |
47 |
Pharmacokinetics of paracetamol in patients with chronic pancreatitis
|
Siepsiak, Magdalena |
|
|
68 |
4 |
p. 733-736 |
artikel |
48 |
Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases
|
Włodarczyk, Marcin |
|
2016 |
68 |
4 |
p. 797-801 5 p. |
artikel |
49 |
Pharmacology and metabolism of infliximab biosimilars — A new treatment option in inflammatory bowel diseases
|
Włodarczyk, Marcin |
|
|
68 |
4 |
p. 797-801 |
artikel |
50 |
Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic)
|
Juszczak, Kajetan |
|
2016 |
68 |
4 |
p. 703-706 4 p. |
artikel |
51 |
Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic)
|
Juszczak, Kajetan |
|
|
68 |
4 |
p. 703-706 |
artikel |
52 |
Possible neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction
|
Kumar, Anil |
|
2016 |
68 |
4 |
p. 764-772 9 p. |
artikel |
53 |
Possible neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction
|
Kumar, Anil |
|
|
68 |
4 |
p. 764-772 |
artikel |
54 |
The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases
|
Włodarczyk, Marcin |
|
2016 |
68 |
4 |
p. 852-858 7 p. |
artikel |
55 |
The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases
|
Włodarczyk, Marcin |
|
|
68 |
4 |
p. 852-858 |
artikel |
56 |
Transdermal immunotherapy: Past, present and future
|
Szczepanik, Marian |
|
2016 |
68 |
4 |
p. 773-781 9 p. |
artikel |
57 |
Transdermal immunotherapy: Past, present and future
|
Szczepanik, Marian |
|
|
68 |
4 |
p. 773-781 |
artikel |